Entrada Therapeutics
TRDA
TRDA
33 hedge funds and large institutions have $386M invested in Entrada Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.
Holders
33
Holders Change
-5
Holders Change %
-13.16%
% of All Funds
0.57%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
4
Increased
14
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$46.8M |
| 2 |
SG
2
StepStone Group
La Jolla,
California
|
$12M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$13.7M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$1.5M |
| 5 |
5
BlackRock
New York
|
$2.33M |
